Karla Therapeutics SAS is a biotech company developing precision therapeutics to alleviate mental health.
Our unique immunological (T cell-) centric approach (i) relies on proof-of-concept data / abundant literature pointing out the role of the immune system in various neuropsychiatric diseases, (ii) supports a precision medicine strategy and (iii) opens to therapeutic applications across various mental disorders as well as autoimmune diseases with psychiatric symptoms.
We aim to pioneer immuno-psychiatry to develop better medicines for the treatment of mental disorders.
Company Details
- Employees
- 2
- Address
- Biopôle Clermont-Limagne, Saint-Beauzire,auvergne-Rhône-Alpes 63360,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://karla-tx.com/
- HQ
- Saint-Beauzire, Auvergne-Rhône-Alpes
Karla Therapeutics Questions
Karla Therapeutics's website is https://karla-tx.com/
Karla Therapeutics's LinkedIn profile is https://fr.linkedin.com/company/karla-therapeutics
Karla Therapeutics has
2 employees.
View email and phone details for 2
employees at Karla Therapeutics.
Karla Therapeutics's industry is
Biotechnology Research
Karla Therapeutics's top competitors are
Osta Therapeutics,
Eg 427,
Odimma Therapeutics,
Kairos Discovery,
Nlc Health Ventures,
Oncosema,
Epilepsygtx,
Ermium Therapeutics,
Adicet Bio, Inc,
Gaoma Therapeutics.
Karla Therapeutics's categories are Biotechnology Research
